BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19443388)

  • 1. Immunohistochemical detection of WT1 protein in endometrial cancer.
    Ohno S; Dohi S; Ohno Y; Kyo S; Sugiyama H; Suzuki N; Inoue M
    Anticancer Res; 2009 May; 29(5):1691-5. PubMed ID: 19443388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between WT1 expression and cell proliferation in endometrial cancer.
    Dohi S; Ohno S; Ohno Y; Soma G; Kyo S; Inoue M
    Anticancer Res; 2009 Nov; 29(11):4887-91. PubMed ID: 20032452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1 expression correlates with angiogenesis in endometrial cancer tissue.
    Dohi S; Ohno S; Ohno Y; Kyo S; Soma G; Sugiyama H; Inoue M
    Anticancer Res; 2010 Aug; 30(8):3187-92. PubMed ID: 20871039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.
    Dupont J; Wang X; Marshall DS; Leitao M; Hedvat CV; Hummer A; Thaler H; O'Reilly RJ; Soslow RA
    Gynecol Oncol; 2004 Aug; 94(2):449-55. PubMed ID: 15297187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of NLRP7 (PYPAF3, NALP7) protein in endometrial cancer tissues.
    Ohno S; Kinoshita T; Ohno Y; Minamoto T; Suzuki N; Inoue M; Suda T
    Anticancer Res; 2008; 28(4C):2493-7. PubMed ID: 18751440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
    Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of Wilms Tumor Gene (WT1) and p53 expression in curettage specimens of patients with endometrial carcinomas.
    Matalka I; Obeidat B; Mohtaseb A; Awamleh A
    Pathol Res Pract; 2013 Jan; 209(1):19-23. PubMed ID: 23207289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
    Mazurek A; Kuc P; Terlikowski S; Laudanski T
    Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
    Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
    Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor gene 1 (WT1) in endometrial carcinoma.
    Coosemans A; Moerman P; Verbist G; Maes W; Neven P; Vergote I; Van Gool SW; Amant F
    Gynecol Oncol; 2008 Dec; 111(3):502-8. PubMed ID: 18929401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the Wilms' tumor gene WT1 in esophageal cancer.
    Oji Y; Yano M; Nakano Y; Abeno S; Nakatsuka S; Ikeba A; Yasuda T; Fujiwara Y; Takiguchi S; Yamamoto H; Fujita S; Kanato K; Ito K; Jomgeow T; Kawakami M; Tsuboi A; Shirakata T; Nishida S; Hosen N; Oka Y; Aozasa K; Monden M; Sugiyama H
    Anticancer Res; 2004; 24(5B):3103-8. PubMed ID: 15510596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
    Sera T; Hiasa Y; Mashiba T; Tokumoto Y; Hirooka M; Konishi I; Matsuura B; Michitaka K; Udaka K; Onji M
    Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence in situ hybridization and immunohistochemical analysis of p53 expression in endometrial cancer: prognostic value and relation to ploidy.
    Graesslin O; Chantot-Bastaraud S; Lorenzato M; Birembaut P; Quéreux C; Daraï E
    Ann Surg Oncol; 2008 Feb; 15(2):484-92. PubMed ID: 18071824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis.
    Ohno S; Ohno Y; Nakada H; Suzuki N; Soma G; Inoue M
    Anticancer Res; 2006; 26(6A):4047-53. PubMed ID: 17195456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade astrocytomas show increased Nestin and Wilms's tumor gene (WT1) protein expression.
    Rushing EJ; Sandberg GD; Horkayne-Szakaly I
    Int J Surg Pathol; 2010 Aug; 18(4):255-9. PubMed ID: 19578047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
    Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
    Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.
    Hylander B; Repasky E; Shrikant P; Intengan M; Beck A; Driscoll D; Singhal P; Lele S; Odunsi K
    Gynecol Oncol; 2006 Apr; 101(1):12-7. PubMed ID: 16263157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100 as an immunohistochemically-detected marker with prognostic significance in endometrial carcinoma.
    Honig A; Schaller N; Dietl J; Backe J; Kammerer U
    Anticancer Res; 2005; 25(3A):1747-53. PubMed ID: 16033094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication.
    Jeon YT; Park IA; Kim YB; Kim JW; Park NH; Kang SB; Lee HP; Song YS
    Cancer Lett; 2006 Aug; 239(2):198-204. PubMed ID: 16168561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone receptor expression in endometrial cancer.
    Jeon YT; Kim YB; Park SY; Kim JW; Park NH; Kang SB; Song YS
    Int J Gynecol Pathol; 2009 Jan; 28(1):19-22. PubMed ID: 19047913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.